Physician

Amy Li, MD

According to 2025 Medicare claims, Amy Li, MD (NPI: 1275823684) practices urology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is FRANCISCAN MEDICAL GROUP (NPI: 1710432612; TIN: 911939739) and primary practice location at 98383-8503. Li is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Jefferson Accountable Care, LLC (ACO ID: A5275), participating under the MSSP model.

Li's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 737 traditional Medicare patients, billed 10,400 HCPCS/CPT codes, and received $336,267 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 1,282 prescription claims across 414 beneficiaries totaling $196,466 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 130 claims. Open Payments data shows 9 records totaling $304. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $54,245 to $336,267. Similarly, Part D prescription costs have moved sharply higher in recent years, from $5,677 to $196,466. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	163	1,201	$54,245
2017	426	6,368	$178,147
2018	477	7,050	$197,485
2019	603	5,682	$266,839
2020	654	5,613	$368,506
2021	586	4,354	$254,252
2022	712	6,109	$433,279
2023	727	7,191	$355,678
2024	737	10,400	$336,267

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	39	60	$5,677
2016	31	48	$4,612
2017	99	286	$39,003
2018	139	370	$54,992
2019	175	505	$67,345
2020	213	646	$95,036
2021	185	541	$67,650
2022	271	745	$107,389
2023	314	959	$147,185
2024	414	1,282	$196,466

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$3,646
2021	N/R	29	$10,144
2022	12	108	$33,167
2023	14	120	$45,654
2024	13	130	$56,782

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	247	289	$166
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	477	742	$96
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	508	716	$12
51798	Ultrasound measurement of bladder capacity after voiding	275	365	$9
81003	Automated urinalysis test	383	553	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	109	7,720	$111,580
Gemtesa	Vibegron	43	2,850	$44,827
Estradiol	Estradiol	242	19,291	$16,673
Tamsulosin Hcl	Tamsulosin Hcl	214	16,325	$3,586
Finasteride	Finasteride	124	10,369	$1,776

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	40	$28,483
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	13	90	$28,299

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$304	PROGENICS PHARMACEUTICALS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amy Li, MD?

Tedicare shows public-source Medicare data for Amy Li, MD (NPI 1275823684), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy Li, MD have ACO affiliation data?

Amy Li, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Jefferson Accountable Care, LLC (MSSP, ACO ID A5275).

What billing organization is linked to Amy Li, MD?

Amy Li, MD is linked to FRANCISCAN MEDICAL GROUP (billing NPI 1710432612) in the available physician profile data.

Does Amy Li, MD have Open Payments data?

Amy Li, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.